Antisense oligodeoxynucleotides (ODNs) have biological activity in treating various forms of cancer. The antisense effects of two types of 20mer ODNs, phosphorothioate-modi®ed ODNs (S-ODNs) and S-ODNs with 12 2¢-O-methyl groups (Me-S-ODNs), targeted to sites 109 and 277 of bcl-2 mRNA, were compared. Both types were at least as effective as G3139 (Genta, Inc.) in reducing the level of Bcl-2 protein in T24 cells following a 4 h transfection at a dose of 0.1 mM. Circular dichroism spectra showed that both types formed A-form duplexes with the complementary RNA, and the melting temperatures were in the order of Me-S-ODN´RNA > normal DNA´RNA > S-ODN´RNA. In comparison with the S-ODN, the Me-S-ODN had reduced toxic growth inhibitory effects, was less prone to bind the DNAbinding domain A of human replication protein A, and was as resistant to serum nucleases. Neither type of oligomer induced apoptosis, according to a PARP-cleavage assay. Hybrids formed with Me-S-ODN sequences were less sensitive to RNase H degradation than those formed with S-ODN sequences. Despite this latter disadvantage, the addition of 2¢-O-methyl groups to a phosphorothioate-modi®ed ODN is advantageous because of increased stability of binding and reduced non-speci®c effects.
INTRODUCTION
Phosphorothioate oligodeoxynucleotides (S-ODNs) were the most common type of the ®rst generation antisense ODNs. These oligomers have resistance to nucleases and the ability to activate RNase H. The major shortcomings of S-ODNs are (i) the relatively low stability of duplexes with complementary RNA and (ii) the toxic effects, possibly related to non-speci®c protein±S-ODN interactions (1±8). Photocrosslinking experiments by others have shown that human replication protein A (RPA) is one of the major protein products crosslinked with single-stranded DNA oligomers (9) .
A prevalent type of second-generation antisense ODN carries 2¢-O-sugar modi®cations, which increases the stability of duplexes with complementary RNA (8) . Duplexes formed with the 2¢-O-sugar-modi®ed S-ODNs themselves do not have the structure needed to activate RNase H cleavage of the target RNA, and such modi®ed S-ODNs are routinely interrupted with a gap of phosphorothioate nucleotides that do not carry the sugar modi®cation. Monia et al. (10) showed that 2¢-Omodi®cations (such as pentyl, propyl, methyl and¯uoro) in chimeric gap-mer S-ODNs had antisense effectiveness that correlated with the T m values of hybrids formed with the target RNA, which was an Ha-ras oncogene in a reporter gene system. Stability of those gap-mers also correlated with the ability to inhibit Ha-ras mRNA expression in T24 cells, at a dose of 100 nM (11) .
McKay et al. (12) found that a gap size of eight was required in 2¢-O-methyl chimeras for optimal reduction of PKCa mRNA in A549 cells. These authors advocated the use of 2¢-O-methoxyethyl-modi®ed sugars, because a 20 nt gapmer with this modi®cation had increased thermal stability when hybridized with the target mRNA and enhanced antisense effectiveness in reducing PKCa mRNA (~85% at 100 nM dose), when compared with an analogous 2¢-O-methyl chimera (~60% at 100 nM dose). In addition, maximum resistance to degradation by snake venom phosphodiesterase was shown to require that chimeras with either 2¢-O-methyl or 2¢-O-methoxyethyl sugars have a uniform phosphorothioatemodi®ed backbone (12) . The 2¢-O-methyl modi®cation remains one of the most valuable 2¢-sugar modi®cations because it is cost-effective. In contrast, 2¢-O-methoxyethylmodi®ed oligomers are not commercially available.
Various antisense modalities need to be carefully compared to determine their relative effectiveness (13) . In this work, we compared 2¢-O-methyl-modi®ed and unmodi®ed S-ODN sequences that are effective in reducing the level of Bcl-2 protein in T24 cells. The anti-apoptotic protein Bcl-2 is localized in the outer mitochondrial membrane, the endoplasmic reticulum and the nuclear envelope (14) . Heterodimerization between pro-and anti-apoptotic members of the Bcl-2 family regulate the release of cytochrome c and subsequent apoptosis (15) . Because of the Bcl-2 protein's anti-apoptotic properties and abilities to inhibit tumor cell apoptosis induced by numerous drugs and radiation, the bcl-2 mRNA is an attractive antisense target for cancer treatment (7, 15, 16) .
We show that non-speci®c effects of phosphorothioates on growth of T24 cells are reduced by the 2¢-O-methyl modi®-cation. The 2¢-O-methyl modi®cation also reduces the binding of S-ODNs to domain A of RPA. Due to reduced non-speci®c effects, 2¢-O-methyl-modi®ed phosphorothioate ODN chimeras may be especially useful, in addition to S-ODNs, for comparative studies.
MATERIALS AND METHODS

Oligonucleotides and protein
Two oligomer sequences were chosen for the present study. Oligomers-109 (5¢-CCGCATCCCACTCGTAGCCC-3¢) and oligomers-277 (5¢-CCGGGCTGAGCGCAGGCCCC-3¢) were 20 nt long and were targeted at starting locations 109 and 277, respectively, of human bcl-2 mRNA (GenBank accession no. M14745). Negative control oligomers-C (5¢-CTCA-TTCCTACCGACACCCC-3¢) were also 20 nt long and consisted of a scrambled sequence that has no homology in the human genome and that was used as a control sequence by others (17) . In preliminary experiments involving 29 S-ODNs targeted to various locations on bcl-2 mRNA, S-ODN-109 was the most effective in reducing Bcl-2 protein in A549 human lung cancer cells by the western blot protocol described below, but using an S-ODN concentration of 0.5 mM. S-ODN-277 was predicted to have the highest duplex stability among the tested oligomers and was as effective as S-ODN-109 in reducing the Bcl-2 level in T24 cells at a concentration of 0.1 mM. The positive control, compound G3139 of Genta, Inc. (Berkeley Heights, NJ), was 18 nt long and was targeted at starting location 32 of human bcl-2 mRNA [reviewed by Dias and Stein (7) ].
The 11 DNA or chimeric oligomers used for this study and the modi®cations they contained are detailed in Table 1 . For convenience, we denote the chimeric oligomers that contain 2¢-O-methyl-modi®ed nucleotides as ODNs, although they contain modi®ed RNA nucleotides. Except for the unmodi®ed ODN-109, all were 100% phosphorothioates. The unmodi®ed ODN, S-ODNs, Me-S-ODN chimeras (with 12 2¢-O-methyl sugars), CmeG-S-ODN chimera (with two 5-methyl cytosines in CpG sequences), and unmodi®ed 20mer RNAs complementary to oligomers-109 and oligomers-277 were purchased from Midland Certi®ed Reagent Co. (Midland, TX). The Me-S-ODN chimeras were HPLC-puri®ed, and the unmodi®ed RNA oligomers were puri®ed using trityl selection. Other oligomers were puri®ed by gel ®ltration. The unmodi®ed RNAs were dissolved in water treated with diethyl pyrocarbonate as in previous work to reduce RNase degradation (18) . Absorption spectra at 90°C (corrected for volume expansion due to heating) were used together with e(260) values (M ±1´c m ±1 , per mole of strand) to determine concentrations of the oligomers dissolved in water (19, 20) . Extinction coef®cients at 260 nm were calculated as the sums of monomer extinction coef®cients; see footnote to Table 1 .
Residues 181±291 of the 70 kDa RPA subunit were expressed in Escherichia coli and puri®ed as described for other RPA domains (21) .
Circular dichroism (CD) spectra and melting temperatures (T m )
CD spectra and melting pro®les were measured as in previous work (18±20). To form double-stranded hybrids for T m The concentrations of lipofectin and ODNs were 3 and 0.1 mM, respectively, in the ®nal mixture. This gave a lipofectin/ nucleotide (+/±) charge ratio of 1.5. (To determine whether the optimal lipofectin/charge ratio might differ for the methylated and unmethylated oligomers, electrophoretic mobility shift assay (EMSA) experiments were performed with S-ODN-109 and 5¢-Me-S-ODN-109 mixed with increasing amounts of lipofectin to give (+/±) charge ratios of 0, 0.5, 1.0, 2.0 and 4.0. Both types of oligomer were partially neutralized at a charge ratio of 1.0 and were fully neutralized at a charge ratio of 2.0. Transfections in this work were therefore all performed with lipofectin/oligomer mixtures at the intermediate charge ratio of 1.5, which, in our experience with S-ODNs, was suf®cient to maximize the antisense effect while minimizing nonspeci®c effects of the lipofectin.) Cells were overlaid with this mixture after prewashing with McCoy's 5A medium. Following a 4 h transfection of cells at 37°C, cells were washed and incubated in McCoy's 5A medium supplemented with 10% FBS for an additional 24 h. Untreated (i.e. mocktreated) controls were identical except that during the treatment period they were overlaid with media without lipofectin or ODNs. (22) . To calculate the reduction of Bcl-2 protein levels, actin band densities of untreated control samples (at 50 and 100% concentrations) and the treated samples were used to calculate the loading ratios of the treated cell lysates. Bcl-2 band intensities of untreated control samples (at 50 and 100% concentrations), with background subtracted, were ®tted with a second-order equation from which the apparent percentages of Bcl-2 protein in the treated samples were determined. These percentages were ®nally corrected for any unequal loading, using the loading ratios from the actin bands.
Western blot analysis
Growth inhibition
The effects on cell growth of the antisense ODNs were determined by [ 3 H]thymidine incorporation (23, 24 
Assay for apoptosis
As a marker of cells undergoing apoptosis, the percentage of PARP [poly(ADP-ribose) polymerase; MW 116 kDa] that was cleaved to give an 89 kDa cleavage product was determined in treated cell lysates by western blot analysis using a PARP antibody (BD Biosciences, San Diego, CA).
Stability of ODNs in serum
To test the stabilities of ODNs in serum, the ODNs (at 10 mM concentration) were incubated in McCoy's 5A medium supplemented with 10% FBS at 37°C. At each time point (0, 24, 48 and 72 h), 12 ml of each mixture was taken and the reaction was terminated by addition of 12 ml of loading buffer (0.1 M Tris±HCl pH 8.4, 0.09 M boric acid, 7 M urea, 0.1% bromophenol blue, 0.01% xylene cyanol). Samples were subjected to electrophoresis in a denaturing 20% polyacrylamide gel with 7 M urea. After electrophoresis, the gels were stained with SYBR Green II (Molecular Probes, Eugene, OR) prepared in TBE (0.089 M Tris base, 0.089 M boric acid and 1 mM EDTA pH 8.0) and scanned with a phosphoimager.
EMSA of RPA70-A binding to ODNs
Two In each of the above cases, the mixtures were subjected to 20% non-denaturing polyacrylamide gel electrophoresis in TBE buffer, the gels were scanned with a phosphoimager, and the data were analyzed using ImageQuant 5.0.
RNase H elicitation
To examine the ability of RNase H to degrade hybrids formed with modi®ed ODNs,~5 pmol of each modi®ed ODN and complementary 32 P 5¢-end-labeled RNA were hybridized in 60 mM Tris±HCl (pH 7.8) containing 2 mM dithiothreitol, 60 mM KCl and 2.5 mM MgCl 2 . The desired hybrid duplexes were formed by incubating at 90°C for 2 min and slow cooling to room temperature for at least 1 h. Then, solutions of hybrids were treated with 0.05 units of Escherichia coli RNase H (Invitrogen) at 37°C for 20 min. Samples were analyzed as in the EMSA experiments described above.
RESULTS
Reductions in Bcl-2 level
In order to determine whether antisense effectiveness correlates with hybridization stabilities of the different ODN modi®cations, T24 human bladder cancer cells were transfected with the modi®ed ODNs targeted to sites 109 and 277 on bcl-2 mRNA. The ODNs were used at a concentration of 0.1 mM. (In preliminary experiments, we found that there were no substantial decreases of Bcl-2 level in T24 cells when the concentrations of S-ODNs or Me-S-ODNs targeted to these two sites were increased above 0.1 mM under our conditions.) As shown in Figure 1 , the S-ODN-109 and 5¢-Me-S-ODN-109 resulted in 57 T 5 and 70 T 2% (SD) reductions of Bcl-2 level, respectively, with the Me-S-ODN having the greater effect. The analogous oligomers targeted to site 277, S-ODN-277 and 5¢-Me-S-ODN-277, resulted in 63 T 4 and 45 T 5% reductions of the Bcl-2 level, respectively. In that case, the Me-S-ODN had the lesser effect. The S-ODN-109 and S-ODN-277 had the same effect, within error, as an effective positive control, G3139, directed against the ®rst six codons of the bcl-2 mRNA (7). The S-ODN and Me-S-ODN controls averaged 3 T 10 and 12 T 10%, respectively, and were not signi®cantly different in their effects on the Bcl-2 level (Fig. 1) .
The level of Raf-1 protein, a protein in a pathway separate from the Bcl-2 pathway, was monitored as an additional indication of non-speci®c cellular effects of the oligomer treatments. For the three Me-S-ODNs used to obtain data for Figure 1 , the level of Raf-1 protein was reduced by an average of 21%, no different from the average of 24% reduction found after treatments by the three 20mer S-ODNs (data not shown).
The antisense effectiveness of three different Me-S-ODN chimeras, all targeted to site 109, were compared to study the effect of placing the 12 2¢-O-methyl groups in one block at the 5¢ end, in one block at the 3¢ end or in two equal blocks at both ends to form a gap-mer. The Me-S-ODN chimeric sequences (5¢-Me-S-ODN, 3¢-Me-S ODN and gap-Me-S-ODN) are shown in Table 1 . The hybrids of these chimeras paired with the target RNA had T m values that differed by only 4°C (Table 1) , and the reductions of Bcl-2 level caused by treatments with the three chimeras were all in the range Table 1 . G3139 is an 18mer S-ODN positive control. Error bars are T1 SD of at least three determinations. The ODN doses were 0.1 mM for Figures 1  and 3 . sequence, the location of the one or two blocks of 2¢-Omethyl nucleotides was unimportant.
Because additional work (below) focused on the oligomers targeted to site 109, we examined whether the reduction of the Bcl-2 level by S-ODN-109 was in¯uenced by the presence of CpG sequences. Synthetic DNAs containing unmethylated CpG dinucleotides can stimulate an immune response in vertebrates, and CpG islands in antisense ODNs can cause non-sequence-speci®c effects (7, 25, 26) . Since sequence 109 contained two CpG islands, an ODN was prepared (CmeG-S-ODN; see Table 1 ) in which C-5-methyl groups were added to cytosines in these CpG sequences to suppress any non-speci®c effects. In simultaneous experiments, the reductions in the Bcl-2 level by S-ODN-109 and CmeG-S-ODN-109 were essentially identical (62 T 4 and 60 T 11%, respectively) demonstrating that the reduction of Bcl-2 level by the S-ODN-109 was not affected by CpG islands. This was not unexpected, since T24 cells are not immune system cells.
From all the data above, we take the reductions in Bcl-2 levels by the S-ODN and Me-S-ODN sequences targeted to sites 109 and 277 to denote primarily the antisense effects of these oligomers.
Although the relative effectiveness of the two types of ODN depended on the target site sequence, the oligomers targeted to site 109 show that an Me-S-ODN can have an apparent antisense effectiveness greater than that of a cognate S-ODN. The actual speci®c activity of the Me-S-ODN may be even greater due to decreased non-speci®c effects, such as a reduced toxic effect on cell growth (see below).
CD spectra of ODN´RNA hybrids
The ODN´RNA duplexes were characterized by CD spectral measurements. CD measurements were performed with the samples in 0.15 M K + (phosphate buffer, pH 7.0), 20°C. The spectra of the ODN´RNA duplexes were signi®cantly different from the averaged spectra of the individual strands (Fig. 2) . Spectra of the hybrids showed an increase in the magnitude of the long wavelength positive band above 260 nm, an increase in the negative band at~210 nm, and a shift in the crossover near 250 nm to shorter wavelengths, relative to the averaged spectra. These CD characteristics are typical features of DNA´RNA duplexes (18, 20) and con®rm the formation of the desired duplexes.
T m values of ODN´RNA hybrids
The S-ODN and Me-S-ODN were further characterized by the stabilities (T m values) of the hybrids they formed with complementary RNAs. The Me-S-ODN´RNA hybrids had relatively high T m values (69°C to above 82°C), but the corresponding S-ODN´RNA hybrids had lower T m values (55 and 66°C). The T m difference between the three chimeric Me-S-ODN-109´RNA hybrids and the S-ODN-109´RNA hybrid was 14±18°C and that between one chimeric Me-S-ODN-277´RNA and the S-ODN-277´RNA was >16°C ( Table 1) . The Me-S-ODNs´RNA hybrids presumably have higher T m values than the corresponding hybrids formed with the S-ODNs because the 2¢-O-methyl group results in an RNA-like conformation, and RNA duplexes have higher T m values than DNA´RNA hybrids (6,18,27,28) .
Growth inhibition by [ 3 H]thymidine incorporation
[ 3 H]Thymidine incorporation in T24 cells was used to assay the inhibition of DNA synthesis and growth inhibitory effects of S-ODN-109 and 5¢-Me-S-ODN-109. As shown in Figure 3 , the same level of growth inhibition was measured for the controls as for the antisense ODNs. These effects were signi®cant for the phosphorothioate-modi®ed oligomer and were minimal for the Me-S-ODN oligomer. There was no effect on [ 3 H]thymidine incorporation by treatment with lipofectin alone (data not shown). We conclude that the effects on growth inhibition by this assay were essentially caused by the cytotoxic effects of the ODN modi®cations and were not secondary to a reduction of the Bcl-2 level.
Apoptosis
We tested whether a reduction in the level of the Bcl-2 antiapoptotic protein was correlated with apoptosis of T24 cells. PARP is one of the main cleavage targets of caspase-3, which is activated in the apoptosis cascade following release of cytochrome c, so that the cleavage of PARP serves as a marker of cells undergoing apoptosis (29) . Cells were treated with ODNs as described in Materials and Methods for reducing the Bcl-2 protein level. The percentage of the 89 kDa PARP cleavage product after treatments with S-ODN-109, 5¢-Me-S-ODN-109, and the two negative controls, ranged from 2 to 6%, not detectably different from the 2% cleavage product found in lysates of untreated controls (data not shown). Thus, according to this assay, there was no detectable apoptotic effect with either the S-ODN-109 of 5¢-Me-S-ODN-109, although these oligomers reduce the Bcl-2 level by 57 and 70%, respectively, and they have differing effects on cell growth according to the [ 3 H]thymidine incorporation assay.
Stability of ODNs in serum
An important consideration in the design of antisense ODN modi®cations is the degree to which the ODN is rendered nuclease resistant. The resistance to degradation in 10% FBS of the unmodi®ed ODN-109 (phosphodiester) and three cognate modi®ed ODNs (the S-ODN, 5¢-Me-S-ODN and Gap-Me-S-ODN) was examined as described in Materials and Methods. The results are shown in Figure 4 . While little of the unmodi®ed ODN remained intact after 24 h, all three of the modi®ed ODNs exhibited a half-life of >72 h in 10% FBS. This was in agreement with results by Gru Ènweller et al. (30) , who reported the half-life of an S-ODN as being >>48 h under similar conditions. Thus, the S-ODN and Me-S-ODN were completely stable over the time course of the transfections and incubations to reduce the level of Bcl-2, and the difference in antisense effect (Fig. 1) was not obviously due to a difference in nuclease stability.
RPA70-A binding af®nities of S-ODN-109 and Me-S-ODN-109
One non-speci®c effect of ODNs is their binding to cellular proteins (1±9). The most abundant single-stranded DNA binding protein in human cells is RPA (31) , and domain A of the 70 kDa subunit of RPA is the site of initial binding to single-stranded DNA (32±34). The binding site of RPA70-A accommodates~5 nt, similar to the binding site size of the Ff g5p, which has been used to assess the effects of different nucleotide modi®cations (6, 32) . Therefore, we determined the relative binding af®nity of RPA for S-ODN-109 and 5¢-Me-S-ODN-109 in both the absence and presence of the complementary RNA sequence.
To compare the RPA70-A binding af®nities for the S-ODN and the Me-S-ODN, saturated S-ODN-109:RPA70-A complexes were prepared with 32 P-labeled S-ODN and various amounts of unlabeled competing S-ODN-109 or Me-S-ODN-109 were added (in phosphate, pH 7.0, 37°C). The EMSA results after 15 min of incubation with the competitor are shown in Figure 5A and B. At an 8-fold excess of unlabeled competing S-ODN,~61% of the labeled S-ODN:RPA70-A complex was completely dissociated (Fig. 5A) . The same results were obtained after up to 4 h of incubation with competing S-ODN-109, indicating that equilibrium had been reached (data not shown). The band of complex became more diffuse as the labeled S-ODN was dissociated because RPA70-A does not bind with high cooperativity, and up to ®ve protein molecules can be bound per ODN 20mer. The same 8-fold excess of competing Me-S-ODN dissociated a maximum of 15% of the S-ODN:RPA70-A complex, 4-fold less than the same amount of competing S-ODN (Fig. 5B) . Additional experiments in which the labeled S-ODN and unlabeled Me-S-ODN were premixed before adding the protein demonstrated that even at a 15-fold excess of Me-S-ODN the amount of completely dissociated labeled S-ODN was still only~15%. Finally, the ratio of 5¢-Me-S-ODN-109 to S-ODN-109 needed for 50% dissociation of an unmodi®ed ODN:RPA70-A complex was determined to be 9.9 T 0.1 (range) in competition experiments (data not shown). In summary, the binding af®nity of RPA70-A was estimated to be~10-fold greater for the S-ODN than for the 5¢-Me-S-ODN, even though the latter has a stretch of eight phosphorothioate nucleotides. In a second type of experiment, we examined the ability of the S-ODN and the 5¢-Me-S-ODN to bind to the complementary RNA in the presence of RPA70-A. At increasing RPA70-A concentrations, the S-ODN´RNA hybrid was less able to form than was the Me-S-ODN´RNA hybrid, as seen in Figure 5C . From quantitation of the results in this Figure, at a [P]/[N] ratio of 0.5, only~25% of the S-ODN was involved in the formation of a S-ODN´RNA hybrid while~80% of the Me-S-ODN was able to form an Me-S-ODN´RNA hybrid. These experiments were consistent with a higher af®nity of RPA70-A for the S-ODN than for the 5¢-Me-S-ODN shown in Figure 5A and B and with a higher T m for the 5¢-Me-S-ODN´RNA hybrid than for the S-ODN´RNA hybrid (Table 1) .
RNase H elicitation
The ability of antisense ODNs to elicit RNase H degradation of the target mRNA is considered to be one of the most important criteria for antisense effectiveness. The S-ODNs and 5¢-Me-S-ODNs targeted to RNA sites 109 and 277 were compared for their ability to recruit RNase H. RNase H degradation of the target RNAs (unmodi®ed 20mer RNAs complementary to oligomers-109 and oligomers-277) was higher for hybrids formed with the S-ODNs than with the Me-S-ODNs (Fig. 6 ). For example,~80% of the hybrid formed with S-ODN-109 was degraded but only~30% of the hybrid formed with Me-S-ODN-109 was degraded under the same conditions. The lowered ability of RNase H to degrade hybrids with the Me-S-ODN was not unexpected. The Me-S-ODNs are chimeric, with 12 nt that are 2¢-O-methyl and RNA-like. Therefore, a major portion of the hybrid formed with the Me-S-ODN sequesters the target RNA in an RNA´RNA duplex that is not recognized by RNase H. The most effective hybrid in recruiting RNase H was that formed by S-ODN-109, which interestingly had the lowest T m .
DISCUSSION
Hybrids formed with 20mer S-ODNs and Me-S-ODNs and their cognate RNA sequences were shown to have the CD spectra of DNA´RNA and RNA´RNA A-form structures (Fig. 2) . As expected, melting temperatures of the hybrids formed with the Me-S-ODNs were above those formed with the S-ODNs (Table 1 ). The two S-ODN sequences whose properties were compared in this work were as effective in reducing the level of Bcl-2 protein in T24 cells as the well studied Bcl-2 antisense sequence G3139 (7) (Fig. 1) , independent of the presence of CpG islands. Treatments with S-ODN-109 and 5¢-Me-S-ODN-109 did not lead to apoptosis according to a PARP-cleavage assay. G3139 also does not induce apoptosis in all cell lines (35) , and Benimetskaya et al. (36) reported that G3139-induced down regulation of Bcl-2 in T24 cells is insuf®cient to decrease cellular viability. Neither S-ODN-109 nor Me-S-ODN-109 oligomers were signi®cantly degraded by serum over the time course of the antisense treatments (Fig. 4) . The latter is important in comparative studies, because without having the nuclease protection of a phosphorothioate backbone the 2¢-O-methyl modi®cation can be less effective in an antisense oligomer than a simple S-ODN (30). Figure 6 . RNase H elicitation of modi®ed ODN´RNA duplexes. With the assumption of equal loading, the percent degradation was calculated from the reduction in the intensity of the DNA´RNA duplex band after RNase H treatment. The complementary 20mer RNAs were 32 P end-labeled. Bands labeled as degraded products in the RNase H negative lanes were from labeled fragments of RNA and over-represent the amount of degradation in the RNA samples because at least two fragments result from a single cleavage. They did not affect the calculation of percent degradation of hybrids by RNase H. Multiple bands of the ODN´RNA duplexes were probably the result of some degradation of the RNA combined with a reduced stability of hybrids formed with the S-ODN. The complexes of RPA70-A with 5¢-Me-S-ODN were more diffuse than those with the S-ODN, likely due to multiple arrangements of up to ®ve protein molecules on the chimeric oligomer.
Eight phosphorothioate nucleotides are needed in gap-mers with 2¢-O-methyl-modi®ed sugars and locked nucleic acids to fully activate RNase H (12, 37) . Oligomers containing 12 2¢-Omethyl-modi®ed nucleotides at the 5¢ ends were less able to induce RNase H degradation of hybridized RNA than were the analogous S-ODNs (Fig. 6) . Nevertheless, the abilities of different chimeric arrangements of the 12 modi®ed nucleotides, in one block at either end or as a gap-mer (5¢-Me-S-ODN, 3¢-Me-S ODN and gap-Me-S-ODN), were equally able to reduce the level of Bcl-2 protein. This implies that slight differences in the ability to activate RNase H are not as important as the ability to form stable hybrids with the target RNA and other factors in antisense effectiveness. Although we did not examine mRNA levels by northern blot analysis in this work, others have shown that antisense phosphorothioate oligomers carrying the 2¢-O-methyl modi®cation are unable to reduce endogenous PKCa mRNA levels unless there is a gap without the sugar modi®cation so that RNase H can be activated (12) . Thus, we reasonably expect that the main mechanism of action of our oligomers in reducing the level of Bcl-2 protein was by RNase H inactivation of the encoding mRNA.
We have shown for the ®rst time that the 2¢-O-methyl modi®cation results in a reduction of important non-speci®c effects. [ 3 H]Thymidine incorporation into DNA has been used by others as a means of assaying cellular growth and proliferation, because dead and dying cells do not incorporate thymidine into their DNA (23, 24) . Under our transfection conditions, oligomers carrying just the phosphorothioate modi®cation were about three times as inhibitory to the growth of T24 cells as oligomers that included 12 2¢-Omethyl-modi®ed nucleotides (Fig. 3) . Moreover, we have determined that the reduced non-speci®c effects of Me-SODNs could be related to their reduced binding to cellular proteins, such as RPA (Fig. 5A and B) . There was a decided decrease in binding af®nity for the RPA70-A domain, by a factor of~10-fold, when 2¢-O-methyl sugars were included in the phosphorothioate ODN. This decrease in binding af®nity for RPA helps ensure that an ODN´RNA hybrid will remain stable in the presence of this cellular protein (Fig. 5C) .
Others have found that S-ODNs and G-tetraplex-forming oligomers bind to nucleolin and that this binding can result in altered cell morphology and apoptosis (38±40). It remains to be determined whether Me-S-ODNs have reduced nucleolinbinding properties, consistent with the possibility that the 2¢-O-methyl modi®cation leads to reduced non-speci®c effects via reduced binding to cellular proteins.
Our previous work with the model Ff g5p single-stranded DNA-binding protein showed that a fully 2¢-O-methyl-modi®ed S-dA 36 oligomer had about one-half of the binding af®nity for g5p as did the simple S-dA 36 oligomer (6) . The use of a model protein such as the g5p, or the RPA70-A domain used in the present study, to assay relative binding af®nities may help establish which nucleotide modi®cations are likely to have reduced non-speci®c effects in cells.
In summary, chimeric ODNs carrying 12 2¢-O-methylmodi®ed nucleotides would be a good choice to include, in addition to simple phosphorothioates, in much needed comparative studies (4) of different antisense molecules. Our results also suggest that there could be a reduction in cost of synthesizing oligomers with 2¢-O-modi®ed sugars by including all 12 modi®ed nucleotides at the 5¢ or the 3¢ end of the oligomers.
